STOCK TITAN

Coherent Corp. Form 4 Filings

COHR NYSE

Every Form 4 that Coherent Corp. (COHR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow COHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COHR filings page.

Rhea-AI Summary

COHERENT CORP. (COHR) director Enrico Digirolomo reported two dispositions of Common Stock on September 11, 2026. He sold 5,315 shares in an open-market or private transaction at $305.985 per share and made a bona fide gift of 1,279 shares to a donor advised fund. No Rule 10b5-1 trading plan is reported for these trades.

Rhea-AI Summary

COHERENT CORP. (COHR) reported that Chief Strategy & Legal Officer Robert P. Beard sold 500 shares of common stock on September 9, 2026 in a sale described as occurring in the open market or through a private transaction at an average price of $309.32 per share. Following this transaction, he directly holds 51,428 shares of Coherent common stock, and no Rule 10b5-1 trading plan is reported for this sale.

Rhea-AI Summary

For Coherent Corp. (COHR), director Lisa Neal-Graves reported selling 2,200 shares of common stock on September 2, 2026 in a sale characterized as an open-market or private transaction at a weighted-average price of $268.42 per share, with individual trade prices ranging from $268.27 to $268.53. After this transaction, she directly holds 13,033 shares of Coherent common stock. No Rule 10b5-1 trading plan is reported for this sale.

Rhea-AI Summary

COHERENT CORP. (COHR) director Enrico Digirolomo reported selling 2,272 shares of common stock on August 31, 2026, at a weighted-average price of $276.8479 per share in open-market or private transactions. The trades were made under a Rule 10b5-1 trading plan adopted on November 21, 2025, and he held 17,238 shares directly after the sale.

Rhea-AI Summary

COHERENT CORP. (COHR) director Stephen A. Skaggs reported selling 2,272 shares of common stock on August 31, 2026. The sale, at a weighted-average price of about $276.88 per share, was executed under a Rule 10b5-1 trading plan adopted on December 3, 2025, leaving him with 14,592 shares held directly.

Rhea-AI Summary

COHERENT CORP. (COHR) received an amended insider report from director Enrico Digirolomo correcting a prior report to include common shares acquired upon option exercises that were previously omitted. The amendment updates the reported number of common shares beneficially owned immediately after the omitted acquisition.

On March 6, 2026, Digirolomo exercised options for 1,005 common shares at $49.90 per share and 2,906 common shares at $36.56 per share, and disposed of the corresponding option positions. On the same date, he acquired those 3,911 shares of common stock through the exercises, sold 3,911 common shares at $241.50 per share, and made a bona fide gift of 1,847 common shares to a donor advised fund. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Summary

COHERENT CORP. (COHR) reported that its Chief Supply Chain Officer, the reporting person, received a grant of 3,358 shares of Common Stock in the form of restricted stock units on August 28, 2026. One-third of this award vests on August 28, 2027, and the remaining two-thirds vest in eight equal quarterly installments beginning November 28, 2027. Following this award, the reporting person holds 21,099 shares directly, including 83 shares previously acquired through COHERENT CORP.’s employee stock purchase plan.

Rhea-AI Summary

COHERENT CORP. (COHR) reported equity compensation changes for Chief Accounting Officer Ilaria Mocciaro. On August 28, 2026, she received 2,335 Deferred Performance Stock Units credited to a deferred compensation plan and two restricted stock unit-related common stock issuances of 1,612 and 2,449 shares. On the same date, 2,174 common shares were withheld at $295.39 per share to satisfy tax obligations, which the company states did not involve an open-market sale.

Rhea-AI Summary

COHERENT CORP. (COHR) reported equity compensation and related tax withholding for CFO and Treasurer Sherri R. Luther. On August 28, 2026, she received a grant of 8,731 shares of common stock in the form of restricted stock units. One-third of these units will vest on August 28, 2027, with the remaining two-thirds vesting in eight equal quarterly installments beginning November 28, 2027. On the same date, 2,594 shares were withheld by the company at $295.39 per share to satisfy her tax obligations, which the company states does not represent an open-market sale. Footnote disclosure also states that her holdings include 243 shares acquired through Coherent Corp.'s employee stock purchase plan.

Rhea-AI Summary

COHERENT CORP. (COHR) reported Form 4 transactions by Chief Technology Officer Julie Sheridan Eng involving equity awards and sales of common stock. On August 28, 2026, she acquired 5,373 shares as a restricted stock unit award and 11,960 shares issued upon payout of Performance Stock Units granted in August 2023; 12,862 shares were withheld by the company at $295.39 per share to satisfy tax withholding obligations. On August 31 and September 1, 2026, she sold 7,047 and 6,030 shares, respectively, at weighted-average prices of $276.83 and $270.69, in transactions effected under a Rule 10b5-1 trading plan adopted on November 21, 2025.

Rhea-AI Summary

COHERENT CORP. (COHR) reported that Chief Strategy & Legal Officer Robert P. Beard received a grant of 5,373 restricted stock units of common stock on August 28, 2026. One-third of the units will vest on August 28, 2027, with the remaining two-thirds vesting in eight equal quarterly installments beginning November 28, 2027. On the same date, 1,896 shares were withheld by the company at $295.39 per share to discharge his tax obligations, which the company states does not constitute an actual sale or open-market transaction. Beard’s holdings also include 243 shares acquired through Coherent Corp.’s employee stock purchase plan.

Rhea-AI Summary

For COHERENT CORP. (COHR), CEO and director James Robert Anderson reported two equity-related transactions on August 28, 2026. He received a grant of 30,564 shares of Common Stock in the form of restricted stock units, with one-third vesting on August 28, 2027 and the remaining two-thirds vesting in eight equal quarterly installments beginning November 28, 2027. On the same date, 11,958 shares of Common Stock were withheld by the company at $295.39 per share to satisfy tax obligations, which the company states does not constitute an open market sale. The report also notes that his holdings include 243 shares acquired through Coherent Corp.'s employee stock purchase plan.

Rhea-AI Summary

COHERENT CORP. (COHR) reported that its Chief Financial Officer, Sherri R. Luther, sold 3,000 shares of common stock on August 18, 2026 at a price of $324.00 per share. After this transaction, she directly holds 64,475 shares of COHERENT CORP. common stock. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025.

Rhea-AI Summary

Coherent Corp. Chief Financial Officer Sherri R Luther sold 1,000 shares of common stock on 2026-07-22 at $306.68 per share in a sale described as an open-market or private transaction. The sale was made under a Rule 10b5-1 trading plan adopted on November 13, 2025, and she now directly holds 67,475 shares.

Rhea-AI Summary

COHERENT CORP. Chief Supply Chain Officer Jeffrey B. Place reported a tax-related share disposition tied to restricted stock vesting. On July 1, 2026, 2,181 shares of common stock were withheld at $394.47 per share to cover withholding taxes and did not involve an open market sale. The withholding arose from the vesting of 6,508 units from a 19,525-share restricted stock unit award granted on July 1, 2025. The remaining 13,017 restricted stock units are scheduled to vest in eight quarterly installments beginning October 1, 2026, subject to continued service, and Place now holds 17,658 shares directly after this transaction.

Rhea-AI Summary

Coherent Corp. CEO James Robert Anderson reported a tax-related share disposition tied to a restricted stock unit (RSU) vesting. On June 3, 2026, 25,836 shares of common stock were withheld at $426.89 per share to satisfy withholding tax obligations.

The withheld shares relate to a 147,214-share RSU award granted on June 3, 2024, which vests in three equal installments beginning on June 3, 2025. After this tax-withholding event, Anderson directly holds 166,438 Coherent shares. The footnotes clarify this is not an open-market sale.

Rhea-AI Summary

COHERENT CORP. director Howard H. Xia reported an option exercise and related stock sales. On May 11, 2026, he exercised options to acquire 2,000 shares of common stock at $21.67 per share, from options that vested in four annual installments beginning August 17, 2017. That same day, he sold 2,000 shares in four open-market transactions at prices between $344 and $368 per share. Following these transactions, Xia directly owned 50,298 shares of Coherent common stock.

Rhea-AI Summary

COHERENT CORP. Chief Financial Officer Sherri R. Luther sold 2,000 shares of Common Stock in an open-market transaction at $372.96 per share. After the sale, she directly holds 68,475 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.

Rhea-AI Summary

Coherent Corp.’s Chief Financial Officer, Sherri R. Luther, reported an open-market sale of 2,000 shares of Common Stock at $351.00 per share. After this transaction, she directly holds 70,475 shares. The sale was carried out under a Rule 10b5-1 trading plan adopted on November 13, 2025, indicating it was pre-arranged rather than a discretionary trade.

Rhea-AI Summary

Coherent Corp. director Howard H. Xia reported a combination of option exercises and share sales. On March 16–17, 2026, he exercised options to acquire a total of 4,240 shares of common stock at an exercise price of $21.67 per share.

Across the same two days, he sold 4,240 common shares in open-market transactions at prices of $258.00, $245.57, $244.46, and $236.22 per share. After these transactions, he directly held 50,298 common shares. The exercised options were from a grant that vested in four equal annual installments beginning on August 17, 2017.

Rhea-AI Summary

COHERENT CORP. Chief Technology Officer Julie Sheridan Eng reported an open-market sale of 1,454 shares of Common Stock on March 10, 2026 at an average price of $258.18 per share. After this transaction, she directly holds 49,436 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025, indicating it was scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

Coherent Corp. director Stephen A. Skaggs sold 3,523 shares of Common Stock in an open-market transaction. The sale occurred on March 9, 2026 at a weighted average price of $243.1309 per share, based on multiple trades between $237.90 and $250.00.

The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025, indicating it was scheduled in advance. Following this sale, Skaggs directly holds 16,864 shares of Coherent Corp. common stock.

Rhea-AI Summary

COHERENT CORP. director Enrico Digirolomo exercised stock options and then reduced his common share holdings through a sale and a charitable gift. On March 6, 2026, he exercised options for 1,005 and 2,906 shares of common stock. He then sold 3,911 common shares in an open-market transaction at $241.50 per share and made a bona fide gift of 1,847 shares to a donor advised fund. After these transactions, he directly owned 15,599 shares of Coherent common stock.

Rhea-AI Summary

Coherent Corp. Chief Technology Officer Julie Sheridan Eng reported an open-market sale of 2,792 shares of common stock on March 2, 2026, at a weighted average price of $291.42 per share. The trade was executed under a Rule 10b5-1 plan adopted on May 14, 2025, leaving her with 50,890 directly owned shares.

Rhea-AI Summary

Coherent Corp.'s Chief Financial Officer, Sherri R. Luther, reported an open-market sale of company stock. On February 12, 2026, she sold 4,000 shares of Coherent common stock at a weighted average price of $217.7386 per share, in transactions that occurred between $210.46 and $223.85 per share. After this sale, she directly owned 72,475 shares of Coherent common stock. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan that she adopted on November 13, 2025.

Rhea-AI Summary

Coherent Corp. director Xia Howard H. reported acquiring 279 shares of common stock through a restricted stock unit award at a grant price of $0 per share on February 11, 2026. After this award, Xia beneficially owns 50,298 shares of Coherent common stock held directly.

The footnote explains that this award will vest on the day immediately prior to Coherent’s next annual meeting of stockholders, which is expected to be November 11, 2026. Vesting is contingent on Xia’s continued service to the company through that date, meaning the shares are subject to forfeiture if service conditions are not met.

Rhea-AI Summary

Coherent Corp. director Sandeep Vij reported an acquisition of 279 shares of common stock, received as a restricted stock unit award at $0 per share on February 11, 2026.

The award will vest on the day immediately prior to the company’s next annual stockholder meeting, which is expected to be November 11, 2026, if he continues serving through that date. Following this grant, he holds 15,954 shares directly and an additional 8,792 shares indirectly through the Vij Family 2001 Trust.

Rhea-AI Summary

Coherent Corp. director Michelle M. Sterling reported receiving 279 shares of common stock as a restricted stock unit award. The award was granted at a price of $0 per share and increases her directly held beneficial ownership to 8,924 shares.

The restricted stock units will vest on the day immediately prior to Coherent Corp.’s next annual stockholder meeting, which is expected to be on November 11, 2026, as long as she continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director Stephen A. Skaggs reported receiving 279 shares of common stock as a restricted stock unit award. The grant was recorded at a price of $0 per share as an equity award, not an open-market purchase. Following this award, he beneficially owns 20,387 shares of Coherent common stock in direct ownership. The units are scheduled to vest on the day immediately prior to Coherent’s next annual stockholders’ meeting, expected on November 11, 2026, provided he continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director Shaker Sadasivam reported an equity award of 279 shares of common stock. These shares were acquired on February 11, 2026 as a restricted stock unit grant at a stated price of $0 per share, reflecting non-cash compensation.

Following this award, Sadasivam directly beneficially owns 41,173 shares of Coherent common stock. The restricted stock units will vest on the day immediately before Coherent’s next annual stockholder meeting, which is expected to be November 11, 2026, if he continues to serve the company through that date.

Rhea-AI Summary

Coherent Corp. director Elizabeth Patrick reported receiving a grant of 279 shares of common stock as a restricted stock unit (RSU) award. The award was granted at a price of $0 per share, reflecting that it is an equity compensation grant rather than an open-market purchase.

After this award, Patrick beneficially owns 5,382 shares of Coherent common stock in total, held directly. According to the award terms, the RSUs will vest on the day immediately prior to Coherent’s next annual stockholders’ meeting, which is expected to be on November 11, 2026, as long as she continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director Lisa Neal-Graves reported an equity award of 279 shares of common stock. These shares were acquired on February 11, 2026 as a restricted stock unit grant at a price of $0 per share, classified as a grant, award, or other acquisition.

Following this award, she beneficially owns 15,233 shares of Coherent common stock in total, held directly. The RSU grant will vest on the day immediately prior to Coherent’s next annual stockholder meeting, which is expected to be November 11, 2026, assuming her continued service to the company through that date.

Rhea-AI Summary

Coherent Corp. director Patricia Hatter reported an equity award in the form of restricted stock units. On February 11, 2026, she acquired 279 shares of common stock at a stated price of $0 per share, described as a grant or award, bringing her directly held stake to 23,859 shares.

The footnote explains that these 279 shares represent a restricted stock unit award that will vest on the day immediately prior to Coherent’s next annual stockholder meeting, which is expected to be on November 11, 2026, provided she continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director David L. Motley reported an equity award of 279 shares of common stock in the form of restricted stock units granted on February 11, 2026 at a price of $0 per share. Following this grant, he directly holds 26,197 common shares. The award will vest on the day immediately prior to Coherent’s next annual stockholders’ meeting, expected on November 11, 2026, if he continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director Michael L. Dreyer reported an equity award of 279 shares of common stock in the form of restricted stock units, granted at a price of $0 per share. Following this grant, he beneficially owns 12,364 common shares directly.

The restricted stock unit award will vest on the day immediately prior to Coherent’s next annual stockholder meeting, which is expected to be on November 11, 2026, provided Dreyer continues to serve the company through that date.

Rhea-AI Summary

Coherent Corp. director Enrico Digirolomo reported an equity award of 279 shares of common stock. The shares were granted as a restricted stock unit award at a price of $0 per share, increasing his directly owned stake to 21,357 shares after the transaction.

The award will vest on the day immediately prior to Coherent’s next annual meeting of stockholders, which is expected to be November 11, 2026. Vesting is conditioned on Digirolomo’s continued service to the company through that date, aligning his compensation with ongoing board service and future company performance.

Rhea-AI Summary

Coherent Corp. director Joseph J. Corasanti received an equity award tied to the company’s common stock. On February 11, 2026, he was granted 279 shares of common stock at a price of $0 per share, reported as a grant, award, or other acquisition.

After this award, he beneficially owned 80,193 shares of Coherent common stock in total, held directly. The grant is structured as a restricted stock unit award that will vest immediately before Coherent’s next annual stockholder meeting, expected on November 11, 2026, provided he continues serving the company through that date.

Rhea-AI Summary

Coherent Corp. director reports stock sale on Form 4. A board member of COHERENT CORP. disclosed selling 15,000 shares of common stock on 12/10/2025 at a price of $196.74 per share. After this transaction, the director beneficially owns 79,914 shares of Coherent common stock in direct ownership. The filing is signed by attorney-in-fact Christopher M. Forrester on 12/12/2025.

Rhea-AI Summary

Coherent Corp. director reported a sale of company stock. On 12/03/2025, the reporting person sold 2,000 shares of Coherent Corp. common stock in an open-market transaction coded as a sale. The weighted average sale price was $164.5111 per share, reflecting multiple trades within a range from $164.41 to $164.54. After this transaction, the director beneficially owned 8,645 shares of Coherent Corp. common stock directly.

Rhea-AI Summary

Coherent Corp.'s Senior Vice President of Finance reported a small insider sale of company stock. On 12/01/2025, the executive sold 1,377 shares of Coherent common stock in an open market transaction coded "S" at a price of $162.71 per share. After this transaction, the officer still beneficially owns 24,033 shares of Coherent common stock, held directly. The filing is signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Summary

Coherent Corp. director reports option exercise and share sales. A director of Coherent Corp. (COHR) exercised an option to acquire 2,000 shares of common stock at an exercise price of $21.67 per share on 12/02/2025. On the same date, the director reported selling 1,000 shares at $168 per share and another 1,000 shares at $172 per share.

Following these transactions, the director reported owning 50,019 shares of common stock directly. The filing also shows an option (right to buy) covering 2,000 underlying shares with an exercise price of $21.67 and an expiration date of 08/20/2026, with 6,240 derivative securities beneficially owned after the reported activity. The option originally vested in four equal annual installments beginning on 08/17/2017.

Rhea-AI Summary

Coherent Corp. director reports stock option exercise and share sale. A company director filed a Form 4 disclosing that on 11/28/2025 they exercised an option to acquire 1,000 shares of Coherent Corp. common stock at an exercise price of $21.67 per share, then sold 1,000 shares of common stock at a price of $158.36 per share on the same date.

Following these transactions, the director beneficially owned 50,019 shares of Coherent Corp. common stock and 8,240 derivative securities (stock options). The reported option originally vested in four equal annual installments beginning on August 17, 2017.

Rhea-AI Summary

Coherent Corp. director reports stock sale

A director of Coherent Corp. (COHR) reported selling 2,831 shares of Coherent common stock on 11/21/2025 at a price of $134.85 per share. After this transaction, the director beneficially owns 21,078 shares of Coherent common stock in direct ownership. The filing is a routine Form 4 disclosure of insider trading activity required by U.S. securities regulations.

Rhea-AI Summary

Coherent Corp. (COHR) reported an insider stock sale by a director. On 11/20/2025, the reporting person sold 2,000 shares of Coherent common stock at a price of $150 per share, as shown in Table I of the filing. The transaction is coded as an open market or similar sale and was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2024. Following this sale, the reporting person beneficially owns 20,108 shares of Coherent common stock, held directly.

Rhea-AI Summary

Coherent Corp. (COHR) reported an insider stock sale by one of its directors. On 11/14/2025, the director sold 11,570 shares of common stock in an open-market transaction coded "S" at a weighted average price of $144.875 per share.

After this sale, the director beneficially owns 12,085 shares of Coherent common stock, held directly. The price reflects multiple sale transactions within a range from $144.85 to $144.96, with the director committing to provide detailed breakdowns of shares sold at each price upon request.

Rhea-AI Summary

Coherent Corp. (COHR): insider Group Form 4 activity

Reporting persons affiliated with Bain Capital converted 54,023 shares of Series B‑1 Convertible Preferred Stock into 7,754,252 shares of Common Stock on November 7, 2025. That same day, they sold 7,500,000 shares at $143.37 per share. The remaining 254,252 shares were distributed on November 10, 2025 to members or partners in connection with charitable gifts, resulting in 0 shares indirectly beneficially owned after the reported transactions. The holdings were reported as indirectly owned through BCPE Watson (DE) BML, LP, with related Bain Capital entities listed as potential shared power holders per footnotes.

Rhea-AI Summary

Coherent Corp. (COHR) Form 4: A director exercised stock options and sold shares on 11/07/2025. The insider exercised 5,700 options at $35.25 and 4,020 options at $49.90, then sold 9,720 shares of common stock at a weighted average price of $151.2489. Following these transactions, the director directly beneficially owned 94,914 shares.

The sale price reflects multiple trades between $151.02 and $151.43, with full breakdowns available upon request.

Rhea-AI Summary

Coherent Corp. (COHR) insider transaction: An executive officer, EVP, General Management, reported selling 60,706 shares of common stock on 11/06/2025 at $160 per share. Following the sale, the reporting person beneficially owned 163,158 shares, held directly.

The filing indicates the sale was made under a pre‑arranged Rule 10b5‑1 trading plan adopted on December 6, 2024. The form was filed by one reporting person and reflects a routine insider transaction disclosure.

Rhea-AI Summary

Coherent Corp. (COHR) insider activity: the company’s EVP, General Management, reported option exercises and open‑market sales on 10/29/2025.

He exercised options to acquire 14,640 shares at $35.25, 17,760 shares at $49.90, and 27,080 shares at $36.56. He then sold 47,751 shares at a weighted average price of $140.4618 (range $140.00–$140.99) and 11,729 shares at a weighted average price of $141.1017 (range $141.00–$141.30). The sales were made under a Rule 10b5‑1 trading plan adopted on December 6, 2024.

Following these transactions, his directly held beneficial ownership was 223,864 shares.

Rhea-AI Summary

Coherent Corp. (COHR) reported an insider transaction on Form 4. A company director sold 2,000 shares of common stock at $140 on 10/29/2025, coded “S.” The sale was made under a Rule 10b5-1 trading plan adopted on 11/21/2024.

Following the transaction, the reporting person beneficially owns 22,108 shares, held directly.